Total investments received (USD): 8.07m
Round value (USD): 1m
Round investors:
Novalis Biotech
Company: Alithea Genomics



Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom